Global Nephrology And Urology Devices Market

Electrosurgical devices and equipment are used for cutting, sealing, and coagulating tissue during a variety of open and laparoscopic surgical procedures. The main products of the electrosurgical devices are electrosurgery generators, electrosurgery instruments and accessories, argon, and smoke management systems. Electrosurgery generators facilitate therapeutic endoscopy by supplying the high-frequency electrical current required to use endoscopic accessories. The applications involved are general surgery, gynecology surgery, urologic surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, and neurosurgery. The various end-users are hospitals, specialized clinics, and ambulatory surgery centres. The electrosurgical devices market research report is one of a series of new reports from The Business Research Company that provides electrosurgical devices market statistics, including electrosurgical devices industry global market size, regional shares, competitors with a electrosurgical devices market share, detailed electrosurgical devices market segments, market trends and opportunities, and any further data you may need to thrive in the electrosurgical devices industry. This electrosurgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global electrosurgical devices and equipment market size will grow from $8.7 billion in 2022 to $9.39 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The electrosurgical devices and equipment market size is expected to grow to $11.45 billion in 2027 at a compound annual growth rate (CAGR) of 5.1%. The increasing prevalence rate of chronic diseases contributed significantly to the growth of the electrosurgical devices and equipment market. The electrosurgical devices are used in the surgery of many life-threatening diseases such as skin cancer, small basal cell carcinomas, squamous cell carcinoma, wound surgery, skin surgery, non-cancerous moles, dentistry, and others. There has been an increase in the number of skin diseases worldwide. For example, in 2021, according to the American Cancer Society, approximately 608,570 Americans died from cancer which was almost 1600 deaths per day.. According to WHO, the global burden of major chronic diseases currently accounts for 43% of all diseases and is set to rise to 60% by 2020. According to a United Nations’ report on world population aging, globally the 60+ aged population is projected to grow by 56% to reach 1.4 billion. The growth of the aging population and rising chronic disease incidence will contribute to increased hospitalization. The increase in the patient pool is expected to rise the demand for electrosurgical devices and equipment. The high incidence of product recalls is one of the factors restraining the electrosurgical devices and equipment market growth. The medical device industry is seeing a significant spike in product recalls during recent years due to defective devices, software issues, mislabeling issues, and quality issues. The electrosurgical devices and equipment market is a minor part of the medical device market and hence, product recall in the electrosurgical market is quite often. For example, in October 2021, Xodus Medical recalled its electrosurgical tip cleaner due to the issue with pouch seal and steril barrier in the tip cleaner. Zimmer Biomet, a medical device company recalled it is class 1 SPF PLUS-Mini and SPF XL IIB Implantable Spinal Fusion Stimulators due to high levels of potentially harmful chemicals which may be toxic to tissues and organs. FDA Safety Communication notice was Magellan Diagnostics and LeadCare of Meridian Bioscience, Inc. for its LeadCare Testing Systems for giving inaccurate test results. Electrosurgery is the application of a high-frequency electric current on biological tissue to create. Technological advances have led to the development of modern ESUs that deliver the medically useful thermal effect. This system is capable of continuously monitoring current and voltage, deriving parameters such as power and tissue resistance, and analyzing them. Depending on the desired treatment outcome, these devices can also keep the operating parameters constant or change them in a targeted manner through control and regulation. Electrosurgical equipment manufacturers should consider investing ESUs to increase market share in the market. The regulatory changes related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes are leading to increased costs of electrosurgical equipment product development and supply to healthcare services organizations. The GDPR is an EU law on the data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. According to a report by Ernst and Young, Fortune 500 companies are spending $7.8 billion to comply with GDPR. In the USA, the U.S. Department of Health and Human Services and Center for Devices and Radiological Health are regulating electrosurgical devices under US FDA. There are two main ways that manufacturers can follow for premarket approval. One way consists of conducting clinical studies and submitting a premarket approval (PMA) application that includes evidence providing reasonable assurance that the device is safe and effective. The other way involves submitting a 510(k) notification demonstrating that the device is substantially equivalent to a device already on the market (a predicate device) that does not require a PMA. The FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The delays in product releases and additional costs incurred due to stringent approval processes put a strain on investments relating to electrosurgical equipment new product development resulting in potential loss of revenue. Major players in the electrosurgical devices market are Bovie Medical Corporation, Johnson & Johnson Private Limited, B. Braun Melsungen AG, Medtronic PLC., Smith and Nephew, Boston Scientific, Stryker Corporation, ATMOS Inc., Heal Force Bio-Meditech Holdings Limited, and Erbe Elektromedizin GmbH. North America was the largest region in the global electrosurgical devices market in 2022. Western Europe was the second-largest region in the electrosurgical devices market. The regions covered in the global electrosurgical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the electrosurgical devices market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The electrosurgical devices and equipment market consists of sales of surgical generators (radiofrequency, ultrasonic, electrocautery, and argon plasma equipment) and electrosurgical instruments (monopolar, bipolar, and ultrasonic instruments). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global electrosurgical devices and equipment market is segmented - 1) By Product: Electrosurgery Generators, Electrosurgery Instruments & Accessories, Argon and Smoke Management Systems  2) By End User: Hospitals, Specialized Clinics, Ambulatory Surgery Centers 3) By Application: General Surgery, Gynecology Surgery, Urologic Surgery, Orthopedic Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery

Anesthetics refer to any refer to any substance, including pain, that causes a local or widespread lack of sensation. Anesthesia suppresses reactions to sensory input by acting on the brain or peripheral nervous system. These drugs are used to give a sense of calm to patients through muscle relaxation, which also causes amnesia. The main types of anesthetics are general anesthetics and local anesthetics. A medically induced coma with a lack of defensive reflexes is known as general anesthesia. It is caused by the injection of one or more general anesthetic drugs. The different routes of administration include Inhalation Anaesthesia Drugs, Intravenous Anaesthesia Drugs, and Topical Anaesthesia Drugs and are used in various applications such as General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, and Other Applications. The anesthetics market research report is one of a series of new reports from The Business Research Company that provides anesthetics market statistics, including anesthetics industry global market size, regional shares, competitors with an anesthetics market share, detailed anesthetics market segments, market trends, and opportunities, and any further data you may need to thrive in the aesthetics industry. This anesthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global anesthetics market size will grow from $9.97 billion in 2022 to $10.49 billion in 2023 at a compound annual growth rate (CAGR) of 5.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anesthetics market size is expected to grow to $12.34 billion in 2027 at a CAGR of 4.1%. The increase in the number of surgeries is one of the major drivers of the anesthetics market due to the applications of anesthetic drugs during surgical procedures. This rise is mainly due to increasing incidents of injuries and accidents that require surgeries. For example, according to WHO's Global status report on road safety, the number of road accidents reached 1.35 million, with approximately 64 deaths for every 100,000 vehicles. Stringent guidelines and regulations imposed by regulatory bodies are one the important restraints for the anesthetics market. These guidelines include conducting clinical trials of newly developed drugs, standards related to patient safety, and monitoring of patients under anesthesia. Complying with these guidelines and getting regulatory approvals consumes a lot of time and negatively impacts the growth of the anesthetics market. For example, the American Society of Anesthesiologists imposes various standards that apply to anesthesia care and monitoring of patients including standards for pre-, basic- and post-anesthesia care and monitoring. Increasing consolidation in the form of acquisitions is an emerging trend in the anesthetics market. This is mainly due to the high level of R&D and intellectual property (IP) investment needed to establish companies that manufacture anesthetic drugs. In this regard, mergers and acquisitions are considered a time and cost-effective methods. Some of the notable acquisitions in recent years include the acquisition ofFDHSAnesthesia LLC by CRH Medical Corporation in 2020, the acquisition of Claris Injectables by Baxter for $625 million, the acquisition of GSK's anesthetics portfolio by Aspen for $238.7 million, and acquisition of Hospira by Pfizer for $17 billion. Major players in the anesthetics market are Baxter, Abbott Laboratories, AstraZeneca, F. Hoffmann-La Roche AG, B. Braun Melsungen AG, AbbVie Inc., Hospira, Aspen, BoehringerIngelheim International GmbH and Eisai Co. Ltd. North America was the largest region in the anesthetics market in 2022. Middle East is expected to be the fastest-growing region in the global anesthetics market during the forecast period. The regions covered in the global anesthetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the anesthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The anesthetics market consists of sales of isoflurane, desflurane, sevoflurane, and nitrous oxide. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global anesthetics market is segmented - 1) By Type: General Anesthetics, Local Anesthetics 2) By Application: General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Other Applications 3) By Route of Administration: Inhalation Anaesthesia Drugs, Intravenous Anaesthesia Drugs, Topical Anaesthesia Drugs 4) By Local Anesthetics: Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Articaine, Benzocaine, Other Local Anesthesia Drugs 5) By General Anesthetics: Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs

ENT surgical devices and equipment are used in ENT surgeries by surgeons and ENT specialists.  The main products in ENT surgical devices and equipment are hand instruments, ENT surgical lasers, powered ENT surgical systems, radiofrequency electrosurgical devices, ENT surgery workstations, an ENT surgical navigation system, an ENT visualization system, and surgical microscopes. These devices and equipment are hand-held devices, portable devices, and fixed devices. The various end-users are hospitals, ambulatory surgical centres, and ENT clinics. The ENT surgical devices and equipment market research report is one of a series of new reports from The Business Research Company that provides ENT surgical devices and equipment market statistics, including ENT surgical devices and equipment industry global market size, regional shares, competitors with a ENT surgical devices and equipment market share, detailed ENT surgical devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the ENT surgical devices and equipment industry. This ENT surgical devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global ent surgical devices and equipment market size will grow from $6.25 billion in 2022 to $6.81 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The ent surgical devices and equipment market size is expected to grow to $9.11 billion in 2027 at a CAGR of 7.5%. Increasing demand and adoption of minimally invasive ENT surgeries will drive the ENT surgical devices and equipment market in the future. For example, minimally invasive ENT surgeries offer patients many benefits such as smaller incisions, faster recovery times, reduced pain, and scarring. In the majority of the cases, physicians enjoy a higher accuracy rate compared to traditional open surgery. These supreme benefits of minimally invasive ENT surgeries will drive the market. Lack of proper reimbursement policies for ENT surgical procedures, especially in developing and developed countries, is one of the major factors that could hinder the growth of the ENT surgical devices and equipment market. ENT surgical procedures are complex, involve greater devices, and thus are relatively expensive. The lack of proper reimbursement policies may inhibit the growth of the ENT surgical devices and equipment market. ENT procedures involving minimally invasive ENT tools are an alternative to major surgeries. It involves less tissue damage, reduced scarring, and faster recovery thereby leading to greater adoption and would see an increase in the market potential. Robot-assisted minimally invasive ENT procedures have transformed the treatment landscape of cancer associated with the ear, nose, and throat. For treating benign and malignant conditions of the oropharynx and larynx, Transoral robotic surgery (TORS) is now being widely adopted. The ENT surgical devices and equipment industry has lately witnessed a rise in the number of FDA clearances which would positively impact the market growth. A pre-market approval by FDA through FDA 510(K) is required for all the medical devices including ENT surgical devices. As announced by the FDA, the FDA 510(K) is expected to see several updates to regulate safety, technology, and capabilities in the medical devices space. The European Union’s Medical Device Regulation (MDR) presented a few changes that would come into force by 2020. The changes made to the regulation were in terms of recertification of legacy devices, as well as changes in the definition of regulated devices, safety measures, and risk management. In 2020, Intersect ENT, a USA-based ear, nose, and throat condition treatment developer, announced to acquire Fiagon for USD 71.1 million. The acquisition was aimed to help Intersect ENT to expand its product portfolio and to extend its geographical reach. Fiagon develops surgical navigation systems that support both routine and complex ENT procedures and is based in Germany. Major players in the ENT surgical devices and equipment market are Carl Zeiss Meditec AG, Stryker, Shanghai Fosun Pharmaceuticals Ltd., KLS Martin LP, Acclarent Inc., Medtronic, Smith & Nephew, Boston Scientific, Olympus, and ClaroNav. Asia-Pacific was the largest region in the global ENT surgical devices and equipment market in 2022. North America was the second-largest region in the ENT surgical devices and equipment market. The regions covered in the global ENT surgical devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in ENT surgical devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The ENT surgical devices and equipment market consists of sales of balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes, and handheld instruments including the otology instrument, rhinology instrument, head and neck surgical instrument, laryngeal instrument, and other handheld instruments that are used for ENT surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global ent surgical devices and equipment market is segmented - 1) By Modality: Hand-held devices, Portable devices, Fixed devices 2) By End User: Hospitals, Ambulatory surgical centers, ENT Clinics 3) By Product: Hand Instrument, ENT Surgical Lasers, Powered ENT Surgical Systems, Radiofrequency Electrosurgical Devices, ENT Surgery Workstations, ENT Surgical Navigation System, ENT Visualization System, Surgical Microscopes

Orthrobiologic devices are implants composed of cells and proteins that are naturally found in the human body and that provide accelerated healing by stimulating efficient regrowth of musculoskeletal tissues, including bones, cartilage, tendons, and ligaments. The main product types of orthobiologics devices and equipment are demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and synthetic orthobiologics. Stem cell therapy is promoting the repair response of diseased, dysfunctional, or injured tissue using stem cells or their derivatives. The various applications involved are osteoarthritis and degenerative arthritis, soft-tissue injuries, fracture recovery, maxillofacial and dental applications, spinal fusion, trauma repair, and reconstructive surgery that are used by various end-users such as hospitals, orthopedic clinics, and others. The orthobiologics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides orthobiologics devices and equipment market statistics, including orthobiologics devices and equipment industry global market size, regional shares, competitors with a orthobiologics devices and equipment market share, detailed orthobiologics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the orthobiologics devices and equipment industry. This orthobiologics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global othobiologics devices and equipment market grew from $4.86 billion in 2022 to $5.29 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The othobiologics devices and equipment market is expected to grow from $6.85 billion in 2027 at a CAGR of 6.7%. The aging population profile of most countries contributed to the growth of orthobiologics devices and equipment market globally. According to the United Nations report, there were 962 million people aged over 60 across the globe, comprising 13% of the global population. The population aged over 60 is expected to grow at a rate of about 3% every year. The report further estimated that Europe had the highest percentage of the population aged over 60. The number of people globally over the age of 65 grew by 33%, according to estimates based on Population Reference Bureau data. The increase in the aging population has increased the patient pool of many orthopedic disorders and led to an increase in the demand for orthobiologics devices and equipment market. Rising incidences of post-surgical complications in patients implanted with orthobiologics devices are one of the major restraints in the orthobiologics devices and equipment market. Surgical procedures with orthobiologics grafts, implants, and devices have become increasingly common in recent years. Major postoperative complications include device failures, bleeding, postoperative infections, immune responses, and rejections. These procedures may develop post-surgery complications which refer to the development of any unwanted or unexpected conditions related to the device, graft, or implant. These complications may vary with the type of procedure, implant, graft, or device, the experience of the surgeon, improper device testing procedures before market launch, device location in the body, and the health and biological response of the individual. The increasing post-operative complications and device failures can limit the orthobiologics devices and equipment market. Biodegradable implants are increasingly being used in orthobiologics treatment and trauma orthopedic surgeries. Biodegradable implants are used to replace a missing biological structure, support a damaged biological structure, and enhance the existing bone structure. Biodegradable products such as re-absorbable polymers composed of polyglycolic acid and polylactic acid manufactured in the form of plates, screws, and pins are replacing traditional devices like plates and screws which are more expensive. Surgeons are preferring biodegradable implants to replace conventional implants, as biodegradable implants can be engineered to provide temporary support for bone fractures, can degrade at a rate matching new tissue formation, eliminate the need for the second surgery, and are highly useful in fracture fixation in children with less implant-related infections. For instance, Stryker Corp. offers orthobiologics such as bone repair biodegradable products that are used in bone regeneration and bone healing, soft tissue regeneration, and muscle connection to bone Regulatory changes are likely to lead to increased costs relating to new product development and supply of orthobiologics devices. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. The GDPR is an EU law on the data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. In November 2017, the USFDA has announced a comprehensive regenerative medicine policy framework to facilitate innovation. This policy deals with the manufacture of tissues, human cells, and cellular and tissue-based products other procedures to prevent the introduction, transmission, and spread of communicable diseases. Orthobiologics such as stem cell therapies are approved through this framework. The potential loss of revenue due to delays in product release, additional costs incurred by the time-consuming approval processes, and changing regulations puts a strain on investments relating to orthobiologics devices development. Major players in the orthobiologics devices and equipment market are Medtronic, Arthrex Inc., DePuy Synthes (A Subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet, Bioventus LLC., Baxter International Inc., Integra Lifesciences Holding Corporation, Nuvasive Inc., and Sanofi. North America was the largest region in the global orthobiologics devices and equipment market in 2022. Western Europe was the second-largest region in the orthobiologics devices and equipment market. The regions covered in global orthobiologics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The counties covered in the orthobiologics devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The orthrobiologic devices market consists of sales of demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and other synthetic orthobiologics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global orthobiologics devices and equipment market is segmented - 1) By Product Type: Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics 2) By Application: Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery 3) By End Use: Hospitals, Orthopedic Clinics, Other End Users

Minimally invasive surgery devices are surgical tools that require fewer incisions of a smaller size or have a quicker healing process. A minimally invasive medical device is implanted inside the patient during surgery. The main product types of minimally invasive surgery devices are handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, monitoring and visualization devices. The electrosurgical devices are used to destroy tissue, incise tissue, and control bleeding by coagulating blood. The various applications of minimal invasive surgery devices are laparoscopy, cardiovascular, cosmetic surgery, orthopedic surgery, obstetrics and gynecology, ophthalmology, neurosurgery, urology, and others that are used by end-users such as hospitals, ambulatory surgical centres (ASCS), and research institutes. The minimally invasive surgery devices market research report is one of a series of new reports from The Business Research Company that provides minimally invasive surgery devices market statistics, including minimally invasive surgery devices industry global market size, regional shares, competitors with a minimally invasive surgery devices market share, detailed minimally invasive surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive surgery devices industry. This minimally invasive surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global minimal invasive surgery devices market grew from $28.98 billion in 2022 to $31.64 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The minimal invasive surgery devices market is expected to grow from $39.48 billion in 2027 at a CAGR of 5.7%. The increasing awareness for minimally invasive surgeries among people is driving the minimally invasive surgery devices market. The minimally invasive surgeries require less/tiny cuts in the skin as compared to traditional surgical methods and aid in lesser pain, short hospital stay, less scarring, minimized chances of bleeding and infections, and low tissue damage. According to the German Heart Surgery Report, the heart operations using ECC (extracorporeal circulation) declined due to achievement of established innovations in minimally invasive therapeutic options in heart surgeries. Furthermore, 51.1% of heart valve operations performed out of the total cardiac surgical procedures in Germany were through the single-valve procedure, out of which 38.5% of them were through minimal invasive heart surgeries. Thus, the growing demand for minimally invasive surgery (MIS) will increase the demand for the minimally invasive surgical devices market. The rising trade barriers are expected to have a negative impact on the minimally invasive surgery devices market growth. Many countries placed trade restrictions, especially on imports, to boost local production. For instance, Brexit is likely to lead to more trade restrictions between the UK and other countries in Europe. The US is also implementing several trade restrictions, especially with China, to boost its local production. For instance, the US government imposed an additional 25% tariff on approximately $16 billion worth of imports from China, including minimally invasive surgical devices and equipment and supplies. These trade restrictions are likely to limit the growth of demand going forward by leading to raised prices. Technologically advanced minimally invasive surgery (MIS) devices with improvements in image guidance, fiber-optics, mini dental implants, and robotic control systems are increasingly opted by patients to treat medical conditions such as aneurysms, cardiac procedures, dental and spinal procedures. Less-invasive surgical procedures with enhanced capabilities in the areas of imaging, micromachining, robotic equipment and components, software systems, and others are becoming popular in the healthcare industry. For instance, video-assisted thoracoscopic surgery (VATS), is a minimally invasive surgical procedure performed to completely remove an organ of the human body to treat traumatic injury, infection, or cancer in the lungs. VATS is performed using a video camera where a small tube called a thoracoscope to which the camera is connected, is inserted through a small incision between the ribs. Furthermore, imaging technology involved in MIS, virtual reality (VR) is becoming a significant area of development. Other MIS techniques are applied to perform surgeries such as single-site laparoscopic surgery, robotic surgeries, needlescopic surgery, cardiac and spinal surgeries, and others. Food and Drug Administration Act (FDA) regulates the minimally invasive surgical devices market in the United States of America. The firms manufacturing robotic minimally invasive surgical devices have to list down any possible risks to health and measures taken by them so that the device addresses health hazards if any stated by FDA. However, the FDA is concerned about the health care providers and patients for not being aware of the safety and effectiveness of these devices as they should not be used in mastectomy procedures or prevention or treatment of cancer. Major players in the minimally invasive surgery devices market are Abbott Laboratories, GE Healthcare, Medtronic PLC., Siemens Healthineers, Smith & Nephew PLC., Medtronic PLC., Stryker Corporation, Boston Scientific Corporation, Ethicon Inc., and B. Braun Melsungen AG. North America was the largest region in the minimally invasive surgery devices market in 2022. Western Europe was the second largest region in the global minimally invasive surgery devices market report. The regions covered in the global minimally invasive surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the minimally invasive surgery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The minimally invasive surgery devices market consists of sales of graspers, retractors/elevators, dilators, suturing instruments, laparoscopes, gastroscope, cystoscope, and ureteroscop. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global minimal invasive surgery devices market is segmented - 1) By Product Type: Handheld Instruments, Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring & Visualization Devices 2) By Application: Laparoscopy, Cardiovascular, Cosmetic Surgery, Orthopedic Surgery, Obstetrics And Gynecology, Ophthalmology, Neurosurgery, Urology, Other Applications 3) By End Users: Hospitals, Ambulatory Surgical Centers (ASCS), Research Institutes

The intensive care unit (ICU) is a specialized ward of a hospital that provides special medical attention to patients who require critical medical care.  The main types of ICU beds on the market are electric beds, semi-electric beds, and manual beds. Electric ICU beds are controlled by a handset or control panel, rather than by medical personnel manually repositioning the bed. The various applications include pediatric intensive care unit, neonatal intensive care unit, psychiatric intensive care unit, cardiac intensive care unit, neurological intensive care unit, trauma intensive care unit, post-operative recovery unit, surgical intensive care unit, and mobile intensive care unit that are used by general and acute care hospitals, specialized hospitals, multi-specialty hospitals, ambulatory surgery centers (ASC), and others. The ICU beds market research report is one of a series of new reports from The Business Research Company that provides ICU beds market statistics, including ICU beds industry global market size, regional shares, competitors with a ICU beds market share, detailed ICU beds market segments, market trends and opportunities, and any further data you may need to thrive in the ICU beds industry. This ICU beds market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global icu beds market will grow from $1.89 billion in 2022 to $2.01 billion in 2023 at a compound annual growth rate (CAGR) of 6.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global icu beds market is expected to grow to $2.62 billion in 2027 at a CAGR of 6.9%. The market for ICU beds is experiencing exponential growth. Increasing COVID-19 cases across the globe pressurizing governments of emerging and developed countries to increase their intensive care capacities. Public health systems releasing funds to procure the needed hospital infrastructure, with ICU beds being one of the important requirements. The frequent outbreaks of pandemic diseases such as Influenza, Ebola, and the recent COVID-19, has put enormous pressure on healthcare authorities and health services to draft and discuss preparedness plans that includes the increase in number of ICU beds, to accommodate critically ill patients. During pandemics, most patients require ICU admission and this drives the market for ICU beds. Even in most well-developed countries, ICU beds are often close to capacity during such out-breaks. In United States, there are an estimated 34.2 ICU beds per 10,000 people, yet there is a surge in demand during recent COVID-19 pandemic. In Italy, there are about 12.5 ICU beds per 10,000 people. Due to the recent outbreak, with the rate of increase in the number of patients in intensive care with COVID-19, the demand for number of ICU beds continues to change. In China and India, it is only 3.6 and 2.3 beds per 10,000 people respectively, and the demand in such developing countries is huge. Patients with severe COVID-19 disease require approximately 14 days of respiratory support in ICU. Such lengthy treatment time will further stress resources. Therefore, the frequent outbreaks of pandemics are expected to drive the market for ICU beds. Critical care is often described as expensive care that includes high cost of resources. In United States, although ICU beds comprise less than 10% of hospital beds, ICU departments consume 22% of total hospital costs. ICU beds tend to cost threefold higher than a bed in a general ward. ICU beds cost between $25,000 and $30,000, significantly more than other medical/surgical beds, which typically cost $5,000 to $10,000 a bed. Bariatric beds are even more expensive, which are nearly about $35,000 to $40,000 each. The escalating demand for critical care services put financial strain on both health care systems, and also on patients who pay completely or partially out-of-pockets for these services. Therefore, high prices of ICU beds are challenging the growth of this market. The launch of smart beds is the key trend gaining popularity in the ICU beds market. Smart beds help to automate and digitalize patient monitoring, improving overall efficiency. The smart beds are designed to facilitate the patient’s movement and help them regain normal movement faster, with the presence of monitoring systems. For example, in August 2022, Dozee, an India based medical equipment manufacturer, partnered with Midmark India, an India based hospital bed manufacturers, and launched a connected bed platform for non-ICU settings. Dozee's sensor-based technology uses artificial intelligence (AI) to track vital parameters of the patient. Major players in the ICU beds market are Invacare Corporation, Paramount Bed Holdings Co. Ltd., Medline Industries Inc., Stiegelmeyer GmBH & Co. KG, Gendron Inc., LINET Group SE, Joerns Healthcare LLC., Span-America Medical Systems Inc., Malvestio S.P.A., and Merivaara Corp. North America was the largest region in the ICU beds market in 2022. Western Europe was the second largest region in the global ICU beds market. The regions covered in the global Intensive Care Unit (ICU) Beds market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the ICU beds market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The Intensive Care Unit (ICU) Beds market consists of sales of gatch beds, low air loss beds, motor powered beds, and collapsible hospital beds. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global ICU beds market is segmented - 1) By Type: Electric Beds, Semi-Electric Beds, Manual Beds 2) By Application: Pediatric Intensive Care Unit, Neonatal Intensive Care Unit, Psychiatric Intensive Care Unit, Cardiac Intensive Care Unit, Neurological Intensive Care Unit, Trauma Intensive Care Unit, Post-Operative Recovery Unit, Surgical Intensive Care Unit, Mobile Intensive Care Unit 3) By End Use: General And Acute Care Hospitals, Specialized Hospitals, Multi-Specialty Hospitals, Ambulatory Surgery Centres (ASC), Other End Uses

Refractive surgery devices and equipment are used in refractive error surgeries, a procedure for correcting or improving vision affected by a refractive error such as nearsightedness (myopia), farsightedness (hyperopia), presbyopia, or astigmatism. The main product types of refractive surgery devices (or) equipment are microkeratome, excimer lasers, femtosecond lasers, and YAG lasers. The excimer laser is a laser that emits concentrated light in the ultraviolet (UV) region of the spectrum. The various applications involved are astigmatism, near-sightedness, and farsightedness that are used by end-users such as hospitals, ambulatory surgical centres, and ophthalmology clinics. The refractive surgery devices (or) equipment market research report is one of a series of new reports from The Business Research Company that provides refractive surgery devices (or) equipment market statistics, including refractive surgery devices (or) equipment industry global market size, regional shares, competitors with a refractive surgery devices (or) equipment market share, detailed refractive surgery devices (or) equipment market segments, market trends and opportunities, and any further data you may need to thrive in the refractive surgery devices (or) equipment industry. This refractive surgery devices (or) equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global refractive surgery devices and equipment market size will grow from $0.15 billion in 2022 to $0.17 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The refractive surgery devices and equipment market size is expected to grow to $0.24 billion in 2027 at a CAGR of 9.5%. A significant driving factor for the growth of the Refractive surgery devices and equipment market is an increase in the geriatric population worldwide with eye disorders. Age-related macular degeneration is the major cause of loss of vision over the age of 65 years. There are many elderly people with refractive errors who require immediate surgical care to cure visual impairment. The rising elderly population throughout the year increases the demand for refractive surgeries. For example, the elderly population in USA is steadily growing and by 2030, 70 million Americans will be over 65 years of age. Approximately one in three older people have optic disorders which are boosting the refractive surgery devices and equipment market. The Refractive surgery devices and equipment market is being restrained due to the lack of use of surgical equipment to treat refractive errors, in developing nations. Also, backwardness, poverty, and lack of knowledge make the patients unaware of the procedures of the surgery. For example, according to WHO the visual impairment in Rwanda, an African country is 5.3% and more than 80% of the eye cases were refractive errors which were considered treatable but due to lack of ophthalmic surgical devices there is no cure. People in developing countries witness more cases related to blindness than in developed countries. The focus areas for many companies in the refractive surgery devices and equipment market has shifted towards increasing technological advancements in the field of refractive surgery. Advanced technologies used for correcting refractive errors expand the scale of the treatment, reduce the time and labor costs. The new corneal refractive surgical techniques such as femtosecond corneal surgery technique, pseudophakic intraocular lenses, intraocular rings and segments, and corneal stiffening techniques such as collagen crosslinking may impact the market significantly. For instance, the intrastromal femtosecond laser-assisted lenticular corneal excision (Flex-Smile) technique is very effective for myopic cases of up to 10 diopters with astigmatism up to 3. Also, the advanced femtosecond laser surgical instruments have many unique features such as complete surgical control down to the micron in terms of diameter, depth and edge angle, fast flap creation. In the USA, FDA (Foods and Drugs Administration) regulates the sale of medical devices and monitors the safety of all regulated medical devices. FDA regulates the sales of medical devices for refractive surgery. Major players in the refractive surgery devices (or) equipment market are Alcon, J & J, Zeiss, Bausch, and Lomb (Valeant), Ziemer Ophthalmic, Nidek, STAAR, Avedro, Lensar, and iVIS Technologies. North America was the largest region in the global refractive surgery devices (or) equipment market in 2022. Asia-Pacific was the second-largest region in the refractive surgery devices (or) equipment market. The regions covered in the global refractive surgery devices (or) equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the refractive surgery devices (or) equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The Refractive surgery devices and equipment market consist of sales of microkeratome, excimer lasers, femtosecond lasers, YAG lasers, and aberrometers that are used for refractive surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global refractive surgery devices and equipment market is segmented - 1) By Product Type: Microkeratome, Excimer Lasers, Femtosecond Lasers, YAG Lasers 2) By End User: Hospitals, Ambulatory Surgical Centres, Opthalmology Clinics 3) By Application: Astigmatism, Near-sightedness, Farsightedness

Robotic surgery is a form of minimally invasive surgery in which doctors insert a succession of extremely small incisions and tiny surgical equipment into a patient's body. Robotic surgery is the process of performing a surgery using tools that are attached to a robotic arm. It is used to perform surgery with high precision. The robotic surgery services are used in various applications such as general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. General surgery is the branch of surgery that deals with the most common surgical procedures. The abdomen, breasts, head and neck, blood arteries, and digestive tract are all treated by general surgeons. They also oversee the treatment of patients who have been wounded, or who have abnormalities or other medical issues that necessitate surgery. The different sectors include hospitals, ambulatory surgery centres (ASCs) and involves various components such as systems, accessories, services. The robotic surgery services market research report is one of a series of new reports from The Business Research Company that provides robotic surgery services market statistics, including robotic surgery services industry global market size, regional shares, competitors with a robotic surgery services market share, detailed robotic surgery services market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery services industry. This robotic surgery services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global robotic surgery services market size will grow from $0.86 billion in 2022 to $1.01 billion in 2023 at a compound annual growth rate (CAGR) of 17.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global robotic surgery services market size is expected to grow to $1.8 billion in 2027 at a CAGR of 15.4%. Increase in purchasing power of hospitals and ambulatory care services has helped in the growth of the robotic surgery service market. Hospitals and ambulatory care services are interested in buying latest technologies to provide advanced care to the patients as well as to achieve an edge over their competitors. According to the fourth quarter and full year financial results 2021 of Intuitive Surgical, the robotic surgical giant, the company shipped 385 da Vinci Surgical Systems in fourth quarter, up 18% from the third quarter's 326 units shipped. In 2021, the company shipped 1,347 da Vinci Surgical Systems, a 44% increase from the 936 systems shipped in 2020.Therefore, the purchasing power of hospital and ambulatory care services coupled with the increase in the geriatric population and prevalence of chronic illness have contributed to the growth of robotic surgery services market. Safety concerns regarding the use of robotic surgery services are likely to cause a hindrance to the robotic surgery services market. According to a study on adverse events with robotic-assisted arthroplasty by American Academy of Orthopedic Surgeons, the unexpected robotic arm movement during bone cuts during TKA was the most common adverse event (AE), accounting for 28.9% of all reported AEs, followed by erroneous bone cuts (12.7%) and the robotic component leaking fluid or having residual contaminants (12.3 percent). Accurate bone resections accounted for more than a quarter of all adverse events associated with robotic-assisted PKA. A registration checkpoint being left in the patient accounted for 43.2 percent of all reported adverse events (AEs) in THA patients. Therefore, the safety issues pertaining to robotic surgeries leading to product recalls is expected to hinder the growth of the robotic surgery services market. The image guide navigation system combined with the robotic surgery system offers more possibility to visualize and perform minimally invasive surgery in areas that were earlier difficult, especially the orthopedic surgeries and neurosurgeries. The Mazor X Stealth system by Medtronic, and the NuVasive's Pulse and Excelsius GPS by Globus Medical, among others use image-guided navigation systems to perform spine surgeries, and orthopaedic implant surgeries such as total, partial knee, and hip replacements as they provide the surgeon with 3D experience. The image-guided navigation reduces the radiation effects and patients do not require to take an X-ray after the procedure. These factors state that the image-guided navigation system is expected to be a trend in robotic surgery services. In February 2022, Medtronic PLC., a US-based medical device company, acquired Digital Surgery for an undisclosed amount. Through this acquisition, Digital Surgery will enhance Medtronic's robotic-assisted surgery platform and expand Medtronic's wider range of products. Digital Surgery is a UK-based is a privately held pioneer in digital education and training, data and analytics, and surgical artificial intelligence (AI). Major players in the robotic surgery services market are Intuitive Surgical Inc., Stryker Corporation, Medrobotics Corporation, Johnson & Johnson, Globus medicals, NuVasive, Smith & Nephew PLC., Titan Medical Inc., TransEnterix Inc. and University of Pittsburgh Medical Centre. North America was the largest region in the robotic surgery services market in 2022. Western Europe was the second largest region in the global robotic surgery services market.The regions covered in the global robotic surgery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the robotic surgery services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The robotic surgery services market includes revenues earned by entities by providing robotic gynaecological services, robotic prostate surgery services, robotic kidney surgery services, and robotic colorectal surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.It does not include revenues from resales either further along the supply chain or as part of other products. The global robotic surgery services market is segmented - 1) By Component: Systems, Accessories, Services 2) By Application: General Surgery, Urological Surgery, Gynecological Surgery, Orthopedic Surgery, Neurosurgery, Other Applications 3) By End-User: Hospitals, Ambulatory Surgery Centers (ASCs)